The Claim
In adults with type 2 diabetes, a 3-month low-carbohydrate diet results in a time in target glucose range (3.9–10 mmol/L) of 93.75%, which is higher than the 80.21% observed with canagliflozin treatment.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults with type 2 diabetes, following a low-carbohydrate diet for three months leads to a higher percentage of time with blood glucose levels within the target range compared to taking canagliflozin.
See the scientific wording
In adults with type 2 diabetes, a 3-month low-carbohydrate diet increases time in target glucose range (3.9–10 mmol/L) to 93.75% compared to 80.21% with canagliflozin, indicating superior glucose stability with dietary intervention.
When a person eats fewer carbohydrates, the liver makes less sugar and the body's cells respond better to insulin, so blood sugar stays within a normal range without large spikes or drops.
What the research says
1 studyIn a study, people with type 2 diabetes who ate fewer carbs spent more time with their blood sugar in the healthy range than those taking a common diabetes pill—93.75% of the time vs. 80.21%.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.